Interferon-gamma assays T-SPOT.TB for the diagnosis of latent tuberculosis infection;Interferonowy test T-SPOT.TB w diagnostyce latentnego zakażenia prątkiem gruźlicy

Pneumonologia i Alergologia Polska

Volumn 79, Issue 4, 2011, Pages 264-271

  Borkowska, Dagmara ^a   Zwolska, Zofia ^a   Michałowska Mitczuk, Dorota ^b   Korzeniewska Koseła, Maria ^b   Zabost, Anna ^a   Napiórkowska, Agnieszka ^a   Kozińska, Monika ^a   Brzezińska, Sylwia ^a   Augustynowicz Kopeć, Ewa ^a  

^a Instytut Biotechnologii Przemys u Rolno Spo ywczego im prof Wac awa D browskiego w Warszawie   (Poland)

^b Instytut Gru licy i Chorób P uc w Warszawie Kierownik   (Poland)

Author keywords

Antigens ESAT 6 and CFP 10; IGRA tests; Interferon ; Latent tuberculosis infection; Tuberculin skin test

Indexed keywords

EID: 79959395585     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Zwolska Z. Robert Koch - twórca bakteriologii chorób zakaźnych. Via Medica, Gdańsk 2006.
2. Augustynowicz-Kopeć E., Zwolska Z. Poste{ogonek}py w diagnostyce i epidemiologii molekularnej Mycobacterium tuberculosis. Konferencja Naukowa ''Mikrobiologia 100 lat po Robercie Kochu'' PTM, Warszawa 2010.
3. Zwolska Z. Koch i jego dokonania - rys historyczny. Konferencja Naukowa ''Mikrobiologia 100 lat po Robercie Kochu'' PTM, Warszawa 2010.
4. Gradmann C. Robert Koch and the white death: from tuberculosis to tuberculin. Microbes Infect. 2006; 8: 294-301.
5. Kruczak K., Skucha W., Duplaga M., Sanak M., Nizankowska-Mogilnicka E. Assessment of the latent tuberculosis infection (LTBI) with QuantiFERON-GIT (QFT-GIT) assay in selected risk groups in Krakow. Borgis - Nowa Medycyna 2009; 1: 37-42.
6. Kang Y. A., Lee H. W., Yoon H. I. i wsp. Discrepancy between the tuberculin skin test and the whole-blood interferon g assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293: 2756-2785.
7. Kruczak K., Nizankowska-Mogilnicka E. The new diagnostics methods of latent tuberculosis infection. Pneumol. Alergol. Pol. 2008; 76: 446-450.
8. Lalvani A. Diagnosing tuberculosis infection in the 21st century. New tools to tackle an old enemy. Chest 2007; 131: 1898-1906.
9. Ferrara G., Losi M., Meacci M. i wsp. Routine hospital use of a new commercial whole blood interferon-g assay for the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med. 2005; 172: 631-635.
10. Ewer K., Deeks J., Alvarez L. i wsp. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. The Lancet 2003; 361: 1168-1173.
11. Paluch-Oleś J., Kozioł-Montewka M. Evaluation of usefulness of QuantiFERON-TB Gold in tube assay and tuberculin skin test for immunodiagnosis of Mycobacterium tuberculosis infection. Borgis - Nowa Medycyna 2009; 1: 32-36.
12. Ferrara G., Losi M., D'Amico R. i wsp. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. The Lancet 2006; 367: 1328-1134.
13. Demkow U. Commentary to the article of K. Kruczak and E. Niżankowska-Moglicka: '' The new diagnostic methods of latent tuberculosis infection''. Pneumonol. Alergol. Pol. 2008; 76: 468-471.
14. Ziołkowski J. Gruźlica dziecie{ogonek}ca. Borgis, Warszawa 2010.
15. Van Leeuwen R.M.L., Bossinka W.J., Thijsen S.F.T. Exclusion of active Mycobacterium tuberculosis complex infection with the T-SPOT.TB assay. Eur. Respir. J. 2007; 29: 605-607.
16. Pai M., Riley L. W., Colford Jr J.M. Interferon-g assay in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 2004; 4: 761-776.
17. Lalvani A. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? CID 2004; 38: 757-759.
18. van Pinxteren L.A.H., Ravn P., Agger E.M., Pollock J., Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP 10. Clin. Diagn. Lab. Immunol. 2000; 2: 155-160.
19. Harboe M., Oettinger T., Wiker H. G. i wsp. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect. Immun. 1996; 64: 16-22.
20. Pai M., Kalantri S., Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev. Mol. Diagn. 2006; 3: 413-422.
21. Stefan D.C., Dippenaar A., Detjen A.K. i wsp. Interferon-gamma release assays for the detection of Mycobacterium tuberculosis infection in children with cancer. Int. J. Tuberc. Lung Dis. 2010; 6: 689-694.
22. Demkow U., Filewska M., Białaś B. i wsp. Antimycobacterial antibody level in pleural, pericardial and cerebrospinal fluid of patients with tuberculosis. Pneumonol. Alergol. Pol. 2004; 72: 105-109.
23. Leung C.C., Yam W.C., Yew W.W. i wsp. T-Spot.TB outperforms tuberkulin skin test in predicting tuberculosis disease. AJRCCM 2010; 182: 834-840.
24. Shams H., Weis S.E., Klucar P. i wsp. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 2005; 1161-1168.
25. Brodie D., Lederer D.J., Gallardo J.S., Trivedi S.H., Burzynski J.N., Schluger N.W. Use of a interferon-g release assay to diagnose latent tuberculosis infection in foreign-born patients. Chest 2008; 4: 869-874.
26. Mazurek G.H., LoBue P.A., Daley C.L. i wsp. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001; 286: 1740-1747.
27. Fietta A., Meloni F., Cascina A. i wsp. Comparison of a wholeblood interferon-gamma assay and tuberculin skin testing in patients with active tuberculosis and individuals at high or low risk of Mycobacterium tuberculosis infection. Am. J. Infect. Control. 2003; 31: 347-353.
28. Nienhaus A., Schablon A., Diel R. Interferon-gamma release assay for the diagnosis of latent TB infection - analysis of discordant results when compared to the tuberculin skin test. PLoS One. 2008; 7: e2665.
29. Lalvani A. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? CID 2004; 38: 757-758.
30. Korzeniewska-Koseła M. Prevention of tuberculosis in patients treated with tumour necrosis factor antagonists. Reumatologia 2010; 48: 4-13.